Gallstones, cholecystectomy, and risk of digestive system cancers

American Journal of Epidemiology

Volumn 179, Issue 6, 2014, Pages 731-739

  Nogueira, Leticia ^a   Freedman, Neal D ^a   Engels, Eric A ^a   Warren, Joan L ^a   Castro, Felipe ^a   Koshiol, Jill ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cancer; cholecystectomy; digestive system; gallstones; gastric cancer; liver; pancreas

Indexed keywords

CANCER; DATABASE; DIGESTIVE SYSTEM; DISEASE INCIDENCE; HEALTH MONITORING; HEALTH RISK; HEALTH SURVEY;

AGED; ARTICLE; CANCER RISK; CHOLECYSTECTOMY; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GALLSTONE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NONCARDIA GASTRIC CANCER; PANCREAS CANCER; PRIMARY TUMOR; SMALL INTESTINE CANCER; SMALL INTESTINE CARCINOID; STOMACH CANCER;

UNITED STATES;

CANCER; CHOLECYSTECTOMY; DIGESTIVE SYSTEM; GALLSTONES; GASTRIC CANCER; LIVER; PANCREAS;

AGED; AGED, 80 AND OVER; CHOLECYSTECTOMY; CONFIDENCE INTERVALS; CONTINENTAL POPULATION GROUPS; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; GALLSTONES; HUMANS; MALE; ODDS RATIO; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84895889334     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt322     Document Type: Article

References (93)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
3. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.
4. Hsing AW, Gao YT, Han TQ, et al. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2007;97(11):1577-1582.
5. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179-1187.e3.
6. Fukuma H, Morshed SA, Watanabe S, et al. Increased expression of cytokines in liver and serum in patients with extrahepatic diseases. J Gastroenterol. 1996;31(4):538-545.
7. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-899.
8. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012; 143(3):550-563.
9. Holzheimer RG. Cholecystitis and cholelithiasis. In: Holzheimer RG, Mannick JA, eds. Surgical Treatment: Evidence-based and Problem-oriented. Munich, Germany: Zuckschwerdt; 2001:722-843.
10. Mahid SS, Jafri NS, Brangers BC, et al. Meta-analysis of cholecystectomy in symptomatic patients with positive hepatobiliary iminodiacetic acid scan results without gallstones. Arch Surg. 2009;144(2):180-187.
11. Sonne DP, Hare KJ, Martens P, et al. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients. Am J Physiol Gastrointest Liver Physiol. 2013;304(4): G413-G419.
12. Engels EA, Pfeiffer RM, Ricker W, et al. Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol. 2011;174(7):860-870.
13. Johnson CJ, Hahn CG, Fink AK, et al. Variability in cancer death certificate accuracy by characteristics of death certifiers. Am J Forensic Med Pathol. 2012;33(2):137-142.
14. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009. Bethesda, MD: National Cancer Institute; 2012.
15. Kalima T, Sjöberg J. Bile reflux after cholecystectomy. Scand J Gastroenterol Suppl. 1981;67:153-156.
16. Miwa K, Hasegawa H, Fujimura T, et al. Duodenal reflux through the pylorus induces gastric adenocarcinoma in the rat. Carcinogenesis. 1992;13(12):2313-2316.
17. Eriksson SG, Lindström CG. Lack of relationship between cholecystectomy and colorectal cancer. A case control autopsy study in a defined population. Scand J Gastroenterol. 1984; 19(7):977-982.
18. Maringhini A, Moreau JA, Melton LJ III, et al. Gallstones, gallbladder cancer, and other gastrointestinal malignancies: an epidemiologic study in Rochester, Minnesota. Ann Intern Med. 1987;107(1):30-35.
19. Gustavsson S, Adami HO, Meirik O, et al. Cholecystectomy as a risk factor for gastric cancer. Dig Dis Sci. 1984;29(2): 116-120.
20. Goldacre MJ, Abisgold JD, Seagroatt V, et al. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer. 2005;92(7):1307-1309.
21. Johansen C, Chow WH, Jørgensen T, et al. Risk of colorectal cancer and other cancers in patients with gall stones. Gut. 1996; 39(3):439-443.
22. Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case-control studies. Ann Oncol. 2012;23(8):2173-2178.
23. Fall K, Ye W, Nyren O. Risk for gastric cancer after cholecystectomy. Am J Gastroenterol. 2007;102(6):1180-1184.
24. Pomare EW, Heaton KW. The effect of cholecystectomy on bile-salt metabolism. Gut. 1973;14(10):753-762.
25. Cohen BI, Raicht RF, Deschner EE, et al. Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. J Natl Cancer Inst. 1980;64(3):573-578.
26. Deschner EE, Cohen BI, Raicht RF. Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation. Digestion. 1981;21(6):290-296.
27. Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case-control studies. Ann Oncol. 2012;23(8):2173-2178.
28. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology. 2001;121(3):542-547.
29. Zuccato E, Venturi M, Di Leo G, et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy. Dig Dis Sci. 1993;38(3):514-519.
30. Breuer N, Goebell H. The role of bile acids in colonic carcinogenesis. Klin Wochenschr. 1985;63(3):97-105.
31. Adami HO, Meirik O, Gustavsson S, et al. Colorectal cancer after cholecystectomy: absence of risk increase within 11-14 years. Gastroenterology. 1983;85(4):859-865.
32. Alley PG, Lee SP. The increased risk of proximal colonic cancer after cholecystectomy. Dis Colon Rectum. 1983;26(8): 522-524.
33. Caprilli R, Ciarniello P, De Petris G, et al. Do colon and rectum exhibit an opposite cancer risk trend versus cholecystectomy? A case-double control study. Ital J Surg Sci. 1989;19(1):29-35.
34. Ekbom A, Yuen J, Adami HO, et al. Cholecystectomy and colorectal cancer. Gastroenterology. 1993;105(1):142-147.
35. Gafà M, Sarli L, Sansebastiano G, et al. Prevention of colorectal cancer-role of association between gallstones and colorectal cancer. Dis Colon Rectum. 1987;30(9):692-696.
36. Mamianetti A, Cinto RO, Altolaguirre D, et al. Relative risk of colorectal cancer after cholecystectomy-a multicenter case-control study. Int J Colorectal Dis. 1988;3(4):215-218.
37. Moorehead RJ, Kernohan RM, Patterson CC, et al. Does cholecystectomy predispose to colorectal cancer-a case control study. Dis Colon Rectum. 1986;29(1):36-38.
38. Paul J, Gessner F, Wechsler JG, et al. Increased incidence of gallstones and prior cholecystectomy in patients with large bowel cancer. Am J Gastroenterol. 1992;87(9):1120-1124.
39. Shao T, Yang Y-X. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol. 2005;100(8):1813-1820.
40. Todoroki I, Friedman GD, Slattery ML, et al. Cholecystectomy and the risk of colon cancer. Am J Gastroenterol. 1999;94(1): 41-46.
41. Turunen MJ, Kivilaakso EO. Increased risk of colorectal cancer after cholecystectomy. Ann Surg. 1981;194(5):639-641.
42. Zeng ZS, Zhang ZF. Cholecystectomy and colorectal cancer in China. Surg Oncol. 1993;2(6):311-319.
43. Berkel J, Hombergen D, Hooymayers IE, et al. Cholecystectomy and colon cancer. Am J Gastroenterol. 1990; 85(1):61-64.
44. Adami HO, Krusemo UB, Meirik O. Unaltered risk of colorectal cancer within 14-17 years of cholecystectomy-updating of a population-based cohort study. Br J Surg. 1987; 74(8):675-678.
45. Gafà M, Sarli L, Sgobba G, et al. Cholelithiasis and colorectal cancer. Ital J Surg Sci. 1984;14(1):43-47.
46. Caprilli R, Pietroiusti A, Chierchini P, et al. Cholecystectomy and colorectal cancer-a retrospective study. Ital J Gastroenterol. 1981;13(1):46-47.
47. Weiss NS, Daling JR, Chow WH. Cholecystectomy and the incidence of cancer of the large bowel. Cancer. 1982;49(8): 1713-1715.
48. Simi M, Leardi S, Siciliano R, et al. Cancer of the large intestine and previous cholecystectomy: does a relationship really exist? Ital J Surg Sci. 1985;15(2):175-180.
49. Friedman GD, Goldhaber MK, Quesenberry CP. Cholecystectomy and large bowel cancer. Lancet. 1987; 329(8538):906-908.
50. Kune GA, Kune S, Watson LF. Large bowel cancer after cholecystectomy. Am J Surg. 1988;156(5):359-362.
51. Negri E, Bosetti C, La Vecchia C, et al. Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer. 1999;35(13):1838-1841.
52. La Vecchia C, D'Avanzo B, Negri E, et al. History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991; 27(5):582-586.
53. Schernhammer ES, Leitzmann MF, Michaud DS, et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer. 2003;88(1): 79-83.
54. Altieri A, Pelucchi C, Talamini R, et al. Cholecystectomy and the risk of colorectal cancer in Italy. Br J Cancer. 2004;90(9): 1753-1755.
55. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 1993;105(1):130-141.
56. Reid FDA, Mercer PM, Harrison M, et al. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol. 1996;31(2):160-169.
57. Attili AF, Angelico M, Cantafora A, et al. Bile acid-induced liver toxicity-relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses. 1986;19(1):57-69.
58. Koga S, Kaibara N, Takeda R. Effect of bile acids on 1,2- dimethylhydrazine-induced colon cancer in rats. Cancer. 1982;50(3):543-547.
59. Tucker ON, Dannenberg AJ, Yang EK, et al. Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis. 2004;25(3):419-423.
60. Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut. 2002;51(3):316-322.
61. Quante M, Bhagat G, Abrams JA, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21(1): 36-51.
62. Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. Langenbecks Arch Surg. 2001;386(3): 224-229.
63. Chow WH, Johansen C, Gridley G, et al. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer. 1999;79(3-4):640-644.
64. Nordenstedt H, Mattsson F, El-Serag H, et al. Gallstones and cholecystectomy in relation to risk of intra-and extrahepatic cholangiocarcinoma. Br J Cancer. 2012;106(5): 1011-1015.
65. Welzel TM, Mellemkjaer L, Gloria G, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer. 2007;120(3): 638-641.
66. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5(10):1221-1228.
67. Lagergren J, Mattsson F, El-Serag H, et al. Increased risk of hepatocellular carcinoma after cholecystectomy. Br J Cancer. 2011;105(1):154-156.
68. Jaunoo SS, Mohandas S, Almond LM. Postcholecystectomy syndrome (PCS). Int J Surg. 2010;8(1):15-17.
69. Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol. 2009;15(14):1677-1689.
70. Hardt PD, Bretz L, Krauss A, et al. Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis. Dig Dis Sci. 2001;46(3):536-539.
71. Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology. 1995;109(1):247-251.
72. Karlson BM, Ekbom A, Josefsson S, et al. The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology. 1997;113(2):587-592.
73. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993;328(20): 1433-1437.
74. Cuzick J, Babiker AG. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer. 1989;43(3): 415-421.
75. Gullo L, Pezzilli R, Morselli-Labate AM. Risk of pancreatic cancer associated with cholelithiasis, cholecystectomy, or gastrectomy. Dig Dis Sci. 1996;41(6):1065-1068.
76. Kalapothaki V, Tzonou A, Hsieh C-C, et al. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control. 1993; 4(4):375-382.
77. Ko AH, Wang F, Holly EA. Pancreatic cancer and medical history in a population-based case-control study in the San Francisco Bay Area, California. Cancer Causes Control. 2007;18(8):809-819.
78. Maisonneuve P, Lowenfels AB, Bueno-de-Mesquita HB, et al. Past medical history and pancreatic cancer risk: results from a multicenter case-control study. Ann Epidemiol. 2010;20(2): 92-98.
79. Schattner A, Fenakel G, Malnick SDH. Cholelithiasis and pancreatic cancer: a case-control study. J Clin Gastroenterol. 1997;25(4):602-604.
80. Hassan MM, Bondy ML, Wolff RA, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007;102(12):2696-2707.
81. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999;80(11): 1830-1837.
82. Ye W, Lagergren J, Nyrén O, et al. Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden. Gut. 2001; 49(5):678-681.
83. Ekbom A, Yuen J, Karlsson BM, et al. Risk of pancreatic and periampullar cancer following cholecystectomy. Dig Dis Sci. 1996;41(2):387-391.
84. Shibata A, Mack TM, Paganini-Hill A, et al. A prospective study of pancreatic cancer in the elderly. Int J Cancer. 1994; 58(1):46-49.
85. Silverman DT. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen. 2001;21(1):7-25.
86. Hyvärinen H, Partanen S. Association of cholecystectomy with abdominal cancers. Hepatogastroenterology. 1987;34(6): 280-284.
87. Smith JP, Solomon TE, Bagheri S, et al. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci. 1990;35(11):1377-1384.
88. Chuang S-C, Vecchia CL, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9-14.
89. Cui Y, Andersen DK. Diabetes and pancreatic cancer. Endocr Relat Cancer. 2012;19(5):F9-F26.
90. Shebl FM, Andreotti G, Rashid A, et al. Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer. 2010;103(1): 115-119.
91. Deng L, Gui Z, Zhao L, et al. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci. 2012;57(6):1576-1585.
92. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172-187.
93. Ryan AM, Duong M, Healy L, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol. 2011;35(4): 309-319.